Quantcast

Latest Pharmaceuticals policy Stories

2014-07-01 23:08:48

Co-Pay Discount, an app which alerts physicians and consumers about discounts on prescription medications, is calling for an end to ‘pay for delay’ deals between drug companies which are slowing down the entry of cheaper generic drugs onto the market after their patents expire. The physicians behind the discount app, which facilitate discounts for health practitioners and their patients, are speaking out about the deals, which could be preventing people from getting their hands on more...

2014-07-01 23:08:35

The recent FDA warning related to Lidocaine is just the latest where labeling has caused some confusion at pharmacies nationwide. The agency warned parents last week that certain oral anesthetics are not safe for teething infants and Ace Innovation Group's app OTCplus is aimed at reducing confusion about OTC medicines. Rock Hill, SC (PRWEB) July 01, 2014 The recent FDA warning related to Lidocaine is just the latest where labeling has caused some confusion at pharmacies nationwide....

2014-07-01 20:22:12

NCMS Announces Plan to Expand North Carolina Drug Card Distribution Sites RALEIGH, N.C., July 1, 2014 /PRNewswire/ -- The North Carolina Medical Society (NCMS) officially announced plans to expand support for North Carolina's free discount drug card program. North Carolina Drug Card, which is free to all North Carolina residents, provides savings of up to 75 percent on prescription drugs at participating pharmacies. The program was launched in August 2007 to help uninsured and...

2014-07-01 08:30:06

- Creates an Innovative New Model in Specialty Pharmaceuticals Leadership - DUBLIN, July 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has completed the acquisition of Forest Laboratories, Inc. (NYSE: FRX) in a cash and equity transaction currently valued at approximately $28 billion. The combination creates one of the world's fastest-growing specialty pharmaceutical companies, with annual revenues of more than $15 billion anticipated for 2015. In...

2014-06-30 23:23:32

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries, and its adoption rate in Europe and North America is very high. http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html (PRWEB) June 30, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-06-30 23:13:21

JoTo PR recently cinched a feature in the North Caroline News Service for client Clearstream, LLC. Clearstream executives were quoted as expert sources with regard to the use of antibiotics on industrial farms, a practice which has now been shown to be contributing to growing antibiotic resistance and the spread of infectious diseases within communities. Tampa Bay, FL (PRWEB) June 30, 2014 Recent studies have surfaced with findings that connect the growth of the antibiotic-resistant...

2014-06-30 23:06:59

Situated in Kalamazoo, Michigan Holistic Health provides patients suffering from a chronic or debilitating conditions with an alternative means of wellness. As a recent addition to the MarijuanaDoctor's network of physicians, this Michigan marijuana doctor will situate thousands of patients with care that truly works. Kalamazoo, Michigan (PRWEB) June 30, 2014 The clinical team at Michigan Holistic Health provides an alternative healthcare environment suitable for patients suffering...

2014-06-30 16:26:55

MOUNTAIN VIEW, Calif., June 30, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice President, Regulatory Affairs. Dr. Kamemoto will have primary responsibility for leading and directing all regulatory affairs and global pharmacovigilence activities. Dr. Kamemoto has been Alexza's Vice President, Regulatory Affairs since July 2012. He joined Alexza in 2006 as...

2014-06-30 08:29:57

ATLANTA, June 30, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced the positive outcome of the Repeat-Use Procedure for ILUVIEN® for the treatment of chronic diabetic macular edema (DME) in an additional 10 European Union countries. Alimera submitted the application through the Mutual Recognition Procedure...

2014-06-29 20:20:49

CHENGDU, China, June 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) attended 2014 China Pharmaceutical International Conference and Exhibit (CPhI China: http://www.cphi-china.cn/) held at Shanghai from June 26(th) till 28(th), 2014 to facilitate...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related